Postprandial triglyceride metabolism in elderly men with subnormal testosterone levels

Asian Journal of Andrology

Volumn 10, Issue 4, 2008, Pages 542-549

  Agledahl, Ingvild ^a,b   Hansen, John Bjarne ^b   Svartberg, Johan ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Abdominal obesity; Postprandial triglycerides; Sex hormone binding globulin; Testosterone; Waist circumference

Indexed keywords

CHYLOMICRON; TESTOSTERONE; TRIACYLGLYCEROL;

AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BODY MASS; CONTROLLED STUDY; FAT TOLERANCE TEST; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; LIPOPROTEIN METABOLISM; MALE; POSTPRANDIAL STATE; WAIST CIRCUMFERENCE;

EID: 45749126104     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1111/j.1745-7262.2008.00387.x     Document Type: Article

References (43)

1. Pekkanen J, Linn S, Heiss G, Suchindran CM, Leon A, Rifkind BM, et al. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med 1990; 322: 1700-707.
2. Lippel K, Tyroler H, Eder H, Gotto A, Jr. Vahouny G. Relationship of hypertriglyceridemia to atherosclerosis. Arteriosclerosis 1981; 1: 406-17.
3. Patsch JR, Miesenbock G, Hopferwieser T, Muhlberger V, Knapp E, Dunn JK, et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 1992; 12: 1336-45.
4. Proctor SD, Mamo JC. Retention of fluorescent-labelled chylomicron remnants within the intima of the arterial wall-evidence that plaque cholesterol may be derived from post-prandial lipoproteins. Eur J Clin Invest 1998; 28: 497-503.
5. Godsland IF, Wynn V, Crook D, Miller NE. Sex, plasma lipoproteins, and atherosclerosis: Prevailing assumptions and outstanding questions. Am Heart J 1987; 114: 1467-503.
6. Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease. Endocr Rev 2003; 24: 313-40.
7. Lichtenstein MJ, Yarnell JW, Elwood PC, Beswick AD, Sweetnam PM, Marks V, et al. Sex hormones, insulin, lipids, and prevalent ischemic heart disease. Am J Epidemiol 1987; 126: 647-57.
8. Khaw KT, Barrett-Connor E. Endogenous sex hormones, high density lipoprotein cholesterol, and other lipoprotein fractions in men. Arterioscler Thromb 1991; 11: 489-94.
9. Svartberg J, von Muhlen D, Mathiesen E, Joakimsen O, Bonaa KH, Stensland-Bugge E. Low testosterone levels are associated with carotid atherosclerosis in men. J Intern Med 2006; 259: 576-82.
10. Hak AE, Witteman JC, de Jong FH, Geerlings MI, Hofman A, Pols HA. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: The Rotterdam study. J Clin Endocrinol Metab 2002; 87: 3632-9.
11. van den Beld AW, Bots ML, Janssen JA, Pols HA, Lamberts SW, Grobbee DE. Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 2003; 157: 25-31.
12. Agledahl I, Skjaerpe PA, Hansen JB, Svartberg J. Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: The Tromsø study. Nutr Metab Cardiovasc Dis 2007 Jun 7 [Epub ahead of print].
13. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84: 3666-72.
14. Nordoy A, Bonaa KH, Sandset PM, Hansen JB, Nilsen H. Relationship between apolipoprotein E polymorphism, postprandial hyperlipemia and hemostatic variables in patients with combined hyperlipemia. Nutr Metab Cardiovasc Dis 2000; 10: 15-23.
15. Olivecrona T, Olivecrona G. Lipoprotein lipase and hepatic lipase in lipoprotein metabolism. In: Betteridge DJ, Illingworth DR, Shepard J, editors. Lipoprotein In Health and Disease. London: Arnold. 1999; p 223-46.
16. Hislop MS, St Clair Gibson A, Lambert MI, Noakes TD, Marais AD. Effects of androgen manipulation on postprandial triglyceridaemia, low-density lipoprotein particle size and lipoprotein(a) in men. Atherosclerosis 2001; 159: 425-32.
17. Barrett-Connor E, Khaw KT. Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation 1988; 78: 539-45.
18. Chen RY, Wittert GA, Andrews GR. Relative androgen deficiency in relation to obesity and metabolic status in older men. Diabetes Obes Metab 2006; 8: 429-35.
19. Couillard C, Bergeron N, Prud'homme D, Bergeron J, Tremblay A, Bouchard C, et al. Postprandial triglyceride response in visceral obesity in men. Diabetes 1998; 47: 953-60.
20. Lewis GF, O'Meara NM, Soltys PA, Blackman JD, Iverius PH, Druetzler AF, et al. Postprandial lipoprotein metabolism in normal and obese subjects: comparison after the vitamin A fat-loading test. J Clin Endocrinol Metab 1990; 71: 1041-50.
21. Blouin K, Despres JP, Couillard C, Tremblay A, Prud'homme D, Bouchard C, et al. Contribution of age and declining androgen levels to features of the metabolic syndrome in men. Metabolism 2005; 54: 1034-40.
22. Svartberg J, von Muhlen D, Sundsfjord J, Jorde R. Waist circumference and testosterone levels in community dwelling men. The Tromsø study. Eur J Epidemiol 2004; 19: 657-63.
23. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Lenrow DA, et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 1999; 84: 2647-53.
24. Khaw KT, Barrett-Connor E. Lower endogenous androgens predict central adiposity in men. Ann Epidemiol 1992; 2: 675-82.
25. Zumoff B, Strain GW, Miller LK, Rosner W, Senie R, Seres DS, et al. Plasma free and non-sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity. J Clin Endocrinol Metab 1990; 71: 929-31.
26. Pasquali R, Vicennati V, Scopinaro N, Marinari G, Simonelli A, Flamia R, et al. Achievement of near-normal body weight as the prerequisite to normalize sex hormone-binding globulin concentrations in massively obese men. Int J Obes Relat Metab Disord 1997; 21: 1-5.
27. Laughlin GA, Barrett-Connor E, Bergstrom J. Low serum testosterone and mortality in older men. J Clin E ndocrinol Metab 2008; 93: 68-75.
28. Mead JR, Irvine SA, Ramji DP. Lipoprotein lipase: Structure, function, regulation, and role in disease. J Mol Med 2002; 80: 753-69.
29. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26.
30. Marin P, Oden B, Bjorntorp P. Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: Effects of androgens. J Clin Endocrinol Metab 1995; 80: 239-43.
31. Rebuffe-Scrive M, Marin P, Bjorntorp P. Effect of testosterone on abdominal adipose tissue in men. Int J Obes 1991; 15: 791-5.
32. Heeren J, Niemeier A, Merkel M, Beisiegel U. Endothelial-derived lipoprotein lipase is bound to postprandial triglyceride-rich lipoproteins and mediates their hepatic clearance in vivo. J Mol Med 2002; 80: 576-84.
33. Breckenridge WC, Little JA, Steiner G, Chow A, Poapst M. Hypertriglyceridemia associated with deficiency of apolipo-protein C-II. N Engl J Med 1978; 298: 1265-73.
34. Brun zell JD, Miller NE, Alaupovic P, St Hilaire RJ, Wang CS, Sarson DL, et al. Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity. J Lipid Res 1983; 24: 12-9.
35. Patsch JR, Prasad S, Gotto AM Jr, Patsch W. High density lipoprotein 2. Relationship of the plasma levels of this lipo-protein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 1987; 80: 341-7.
36. Schaefer EJ, McNamara JR, Tayler T, Daly JA, Gleason JA, Seman LJ, et al. Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects. Am J Cardiol 2002; 90: 689-96.
37. Karpe F. Postprandial lipemia-effect of lipid-lowering drugs. Atheroscler Suppl 2002; 3: 41-6.
38. Gwynne JT, Strauss JF 3rd. The role of lipoproteins in steroidogenesis and cholesterol metabolism in steroidogenic glands. Endocr Rev 1982; 3: 299-329.
39. Dobs AS, Miller S, Neri G, Weiss S, Tate AC, Shapiro DR, et al. Effects of simvastatin and pravastatin on gonadal function in male hypercholesterolemic patients. Metabolism 2000; 49: 115-21.
40. Stein EA, Davidson MH, Dobs AS, Schrott H, Dujovne CA, Bays H, et al. Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients. The Expanded Dose Simvastatin U.S. Study Group. Am J Cardiol 1998; 82: 311-6.
41. . Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 1994; 106: 83-97.
42. Simons LA, Dwyer T, Simons J, Bernstein L, Mock P, Poonia NS, et al. Chylomicrons and chylomicron remnants in coronary artery disease: A case-control study. Atherosclerosis 1987; 65: 181-9.
43. Bradley WA, Gianturco SH. Triglyceride-rich lipoproteins and atherosclerosis: Pathophysiological considerations. J Intern Med Suppl 1994; 736: 33-9.